KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Interest Coverage Ratio (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Interest Coverage Ratio for 8 consecutive years, with 18.42 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 10090.73% year-over-year to 18.42, compared with a TTM value of 4.32 through Dec 2025, up 16848.58%, and an annual FY2025 reading of 4.32, up 16848.58% over the prior year.
  • Interest Coverage Ratio was 18.42 for Q4 2025 at Biocryst Pharmaceuticals, up from 1.51 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 18.42 in Q4 2025 and bottomed at 0.78 in Q4 2023.
  • Average Interest Coverage Ratio over 3 years is 2.37, with a median of 0.35 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio skyrocketed 76.37% in 2024, then surged 10090.73% in 2025.
  • Year by year, Interest Coverage Ratio stood at 0.78 in 2023, then soared by 76.37% to 0.18 in 2024, then surged by 10090.73% to 18.42 in 2025.
  • Business Quant data shows Interest Coverage Ratio for BCRX at 18.42 in Q4 2025, 1.51 in Q3 2025, and 1.38 in Q2 2025.